Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug indicated for postoperative inflammation in patients who have undergone cataract surgery.
The brand is joining the International League of Dermatological Societies and the International Society of Dermatology to spread skin health awareness in underserved communities on July 8.